CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$588,567
-31.0%
46,271
-23.6%
0.00%0.0%
Q2 2023$852,544
-15.2%
60,550
-7.0%
0.00%0.0%
Q1 2023$1,005,393
+15.3%
65,074
+22.4%
0.00%0.0%
Q4 2022$871,669
-9.4%
53,183
+2.3%
0.00%
-50.0%
Q3 2022$962,000
+49.4%
51,978
+6.2%
0.00%
+100.0%
Q2 2022$644,000
+35.0%
48,953
-4.8%
0.00%0.0%
Q1 2022$477,000
-12.2%
51,413
-7.5%
0.00%0.0%
Q4 2021$543,000
-70.6%
55,595
+2.2%
0.00%
-50.0%
Q3 2021$1,849,000
-6.9%
54,408
+0.3%
0.00%0.0%
Q2 2021$1,987,000
-23.9%
54,265
-6.8%
0.00%
-33.3%
Q1 2021$2,610,000
-20.7%
58,217
+0.9%
0.00%
-40.0%
Q4 2020$3,291,000
+12.8%
57,673
+1.4%
0.01%0.0%
Q3 2020$2,917,000
-13.4%
56,863
+0.8%
0.01%
-16.7%
Q2 2020$3,369,000
+156.8%
56,409
+77.0%
0.01%
+100.0%
Q1 2020$1,312,000
-30.1%
31,874
+5.7%
0.00%0.0%
Q4 2019$1,877,000
+87.1%
30,152
+2.1%
0.00%
+50.0%
Q3 2019$1,003,000
+95.5%
29,544
+29.9%
0.00%
+100.0%
Q2 2019$513,000
+60.3%
22,739
+65.2%
0.00%0.0%
Q1 2019$320,000
+10.7%
13,7670.0%0.00%0.0%
Q4 2018$289,000
-44.2%
13,767
+2.9%
0.00%0.0%
Q3 2018$518,000
+13.1%
13,373
+14.9%
0.00%0.0%
Q2 2018$458,000
+78.9%
11,643
-8.7%
0.00%0.0%
Q1 2018$256,000
-13.2%
12,750
-2.0%
0.00%0.0%
Q4 2017$295,00013,0070.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,086,723$85,910,00025.70%
SV Health Investors, LLC 449,951$18,525,00015.54%
Redmile Group, LLC 5,116,263$210,637,0005.90%
Eversept Partners, LP 414,081$17,047,7154.24%
Sunesis Advisors, LLC 96,299$3,965,0003.99%
Avoro Capital Advisors LLC 2,000,000$82,340,0002.78%
Opaleye Management Inc. 222,000$9,140,0002.42%
SECTORAL ASSET MANAGEMENT INC 204,059$8,401,0001.61%
Artal Group S.A. 800,000$32,936,0001.39%
Atika Capital Management LLC 141,000$5,805,0001.11%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders